Baird Capital

Baird Capital, established in 1989, is a global investment firm specializing in private equity and venture capital. It focuses on lower middle-market and mature companies, primarily in the United States and Europe, with additional presence in Asia. Baird Capital invests in various sectors such as healthcare, technology-enabled services, industrial technology, and financial technology. The firm seeks controlling ownership in companies with revenues between $15.99 million and $159.94 million, EBITDA between $3.2 million and $12.79 million, and enterprise values between $10 million and $159.94 million. Baird Capital works closely with company executives and founders to build world-class businesses, leveraging its deep sector knowledge and global network of investment professionals.

Wolfgang Alvano

Managing Director

Joanna Arras

Partner

Jubril Ayanbunmi

Investment Manager

James Benfield

Partner

Alfredo Bequillard

Managing Director, Capital Advisory

Timothy Byrne

Chief Information Officer and Managing Director

Thomas Coburn

Director and Global Industrial Group Member

Tom Costello

Principal

Aidan Elliott

Investment Director

Danielle Farmer

Investment Banking, Financial Sponsors Group - Vice President

Andrew Ferguson

Partner

Jonathan Fitzsimmons

Managing Director, Investment Banking

David Fraser

Operating Partner

Thomas Glynn

Senior Vice President, Private Wealth Management

Alexandra Goldman

Associate

David Gregorka

Venture Partner

Huaming Gu

Partner

Matthew Gura

Associate

Dennis Hall

Partner and Global Head of Portfolio Operations

Michael Holgate

Partner

Gina Kim

Vice President, Knowledge Services and Market Data

Louise Kingston

Director

Anjan Krishna

Associate, Private Equity

Jon Langenfeld

Managing Director, Head of Global Equities and Director of Equity Research

Derrick Li

Managing Director

Michael Liang

Partner, US Venture Capital - Healthcare

Mike Magluilo

Managing Director, Technology and Services Group

Terry Maxwell

CFO

John Neis

Principal and Managing Director

Gordon Pan

President, Baird Capital

James E. Pavlik

Partner

Samuel Pollard

Investment Associate

Summer Powers

Associate

John Reim

Associate

Frederick Robertson

Venture Partner

Benedict Rocchio

Partner

Chase Sanders

Managing Director

David Schroeder

Operating Partner

Daina Spedding

Director

Bill Suddath

Managing Director, Co-Head of Global Healthcare Investment Banking

Andrew Szyman

Associate

Brett Tucker

Partner

Ross Wright

Associate

Milord Yip

Vice President, Investments

Yongshan Zhang

Principal

Jason Zhao

Venture Partner

Anthony Zhu

Principal

Past deals in Midwestern US

ModelOp

Series B in 2024
ModelOp, Inc. is a provider of enterprise software that automates the deployment, monitoring, and governance of artificial intelligence models across various platforms and technologies. Founded in 2001 and headquartered in Chicago, Illinois, with additional offices in Salt Lake City and San Jose, the company serves Fortune 1000 clients in sectors such as financial services, manufacturing, and healthcare. ModelOp's platform enables executives, data scientists, and IT professionals to effectively manage AI initiatives, including generative AI and large language models, while maintaining innovation. It offers a comprehensive view of all models within an organization, allowing users to implement business and technical controls through a rules-based engine, and orchestrates the entire model lifecycle with integration to DevOps. This approach addresses critical governance challenges and enhances the value derived from enterprise AI initiatives.

Parallax

Series B in 2023
Parallax, founded in 2019 and based in Edina, Minnesota, develops innovative tools designed to foster a shared perspective across organizations. The company focuses on assisting digital services firms in enhancing their profit margins, increasing revenue, and achieving sustainable growth through predictive resourcing and active forecasting. By providing a curated perspective and an integrated toolset, Parallax aims to empower growth-oriented digital service providers to make informed strategic decisions. This approach minimizes the emotional and operational challenges associated with traditional in-house tools and monolithic platforms that often isolate critical data and decision-making processes.

Zylo

Series C in 2022
Zylo, Inc. operates a software-as-a-service (SaaS) management platform that assists enterprises in managing their cloud-based applications. Founded in 2015 and based in Indianapolis, Indiana, Zylo enables organizations to discover applications, manage licenses, and optimize spending on SaaS solutions. The platform provides visibility into SaaS usage and expenditures, allowing businesses to build renewal calendars and foster IT collaboration while containing costs. Zylo's patent-pending, AI-powered Discovery Engine continuously monitors SaaS spend and usage, offering actionable insights to optimize SaaS portfolios. With a focus on enhancing the employee experience, Zylo's technology is trusted by various organizations to manage over 30 million SaaS licenses and $7 billion in SaaS expenditures.

Upfront Healthcare Services

Series C in 2022
Upfront Healthcare Services, Inc. is a Chicago-based company that specializes in creating a data analytics platform aimed at enhancing the ambulatory care experience for patients and healthcare providers. Founded in 2015, the company focuses on automating and personalizing care navigation to improve patient engagement and optimize resource allocation within physician practices. Its platform, known as Care Traffic Control, utilizes advanced analytics and personalized content to guide patients to the most appropriate care options, thereby increasing appointment efficiency and improving clinical outcomes. By leveraging a variety of data sources—including demographics, billing, scheduling, claims, and care gaps—Upfront Healthcare Services ensures that patient needs are effectively matched with available healthcare resources.

Autobooks

Series C in 2022
Autobooks, Inc. is a provider of integrated payment and accounting software tailored for small businesses. Founded in 2015 and based in Detroit, Michigan, the company offers an intelligent, cloud-based platform that seamlessly integrates with bank accounts, facilitating cash flow management, account reconciliation, and business growth. Through its services, Autobooks enables financial institutions to deliver essential back-office functions and an e-commerce platform directly within their digital banking channels. Its product suite includes features for invoicing, bill pay, merchant services, treasury products, and automated accounting, all designed to simplify financial management for small businesses. The company, originally known as Automated Booking, Inc., rebranded to Autobooks, Inc. in March 2018.

Vodori

Series A in 2021
Vodori, Inc. is a software development company based in Chicago, Illinois, that specializes in providing solutions for life sciences companies. Founded in 2005, Vodori focuses on simplifying the creation, approval, and distribution of regulated promotional content for the pharmaceutical, biotechnology, medical device, and diagnostic industries. Its cloud-based platform offers a suite of products that includes tools for promotional and medical information, sales enablement, and analytics. By delivering actionable insights, Vodori helps its clients make more effective marketing decisions while reducing costs and risks associated with regulatory compliance. This enables life science companies to optimize essential processes and bring vital drugs, vaccines, and medical devices to market more efficiently.

Strata Oncology

Series C in 2021
Strata Oncology, Inc. is a precision oncology company focused on improving cancer care by increasing patient access to clinical trials and expediting drug approvals. The company operates a national precision oncology platform that connects patient screening to streamlined enrollment in mutation-matched clinical trials. Strata collaborates with major healthcare systems to facilitate the genomic sequencing of cancer patients' biopsies in high-throughput laboratories, providing oncologists with timely tumor profiles that inform treatment decisions. Its offerings include The Strata Trial, StrataNGS for targeted DNA and RNA sequencing, and StrataPOINT, which integrates electronic medical records with molecular data to ensure comprehensive testing and follow-up for eligible patients. Strata also manages a portfolio of pharmaceutical-sponsored trials tailored to specific biomarkers and operates the Strata Precision Oncology Network, a collaborative effort among cancer centers to advance precision medicine. Founded in 2015 and headquartered in Ann Arbor, Michigan, Strata was previously known as Strata Oncology Research, Inc. until its name change in May 2016.

Upfront Healthcare Services

Series B in 2020
Upfront Healthcare Services, Inc. is a Chicago-based company that specializes in creating a data analytics platform aimed at enhancing the ambulatory care experience for patients and healthcare providers. Founded in 2015, the company focuses on automating and personalizing care navigation to improve patient engagement and optimize resource allocation within physician practices. Its platform, known as Care Traffic Control, utilizes advanced analytics and personalized content to guide patients to the most appropriate care options, thereby increasing appointment efficiency and improving clinical outcomes. By leveraging a variety of data sources—including demographics, billing, scheduling, claims, and care gaps—Upfront Healthcare Services ensures that patient needs are effectively matched with available healthcare resources.

Autobooks

Series A in 2020
Autobooks, Inc. is a provider of integrated payment and accounting software tailored for small businesses. Founded in 2015 and based in Detroit, Michigan, the company offers an intelligent, cloud-based platform that seamlessly integrates with bank accounts, facilitating cash flow management, account reconciliation, and business growth. Through its services, Autobooks enables financial institutions to deliver essential back-office functions and an e-commerce platform directly within their digital banking channels. Its product suite includes features for invoicing, bill pay, merchant services, treasury products, and automated accounting, all designed to simplify financial management for small businesses. The company, originally known as Automated Booking, Inc., rebranded to Autobooks, Inc. in March 2018.

NowSecure

Series B in 2019
NowSecure, Inc. specializes in mobile app security testing software and services, providing solutions designed to identify security threats, compliance gaps, and privacy issues in both custom-developed and commercial mobile applications. The company's flagship offerings include the NowSecure Platform, which automates security and privacy testing for mobile apps, and NowSecure Workstation, a comprehensive kit that streamlines mobile app vulnerability assessments. Additionally, NowSecure Data continuously monitors commercial applications for security and compliance risks, while NowSecure Services offers manual penetration testing, developer training, and technical support. Founded in 2009 and headquartered in Chicago, Illinois, NowSecure serves various sectors, including financial services, retail, hospitality, and government. The company emphasizes efficient security testing, aligning its services with Agile and DevSecOps methodologies to ensure that clients can rapidly address vulnerabilities in their mobile applications.

Hireology

Series D in 2019
Hireology, Inc. is a Chicago-based company that offers a web-based hiring management software platform designed to help businesses source, engage, and hire top talent. Founded in 2009, it provides an all-in-one solution that streamlines the hiring process by integrating features such as a fully-hosted career site, job postings, pre-hire assessments, and background checks. The platform is particularly tailored for decentralized organizations, including franchise systems, banks, healthcare systems, and dealer networks. By leveraging data on high-performing employees, Hireology's Selection Manager enables organizations to make better hiring decisions, reduce turnover, and enhance productivity across multiple locations. Its comprehensive approach also includes managing employee onboarding, payroll, and benefits, making it a valuable resource for businesses aiming to build effective teams.

Hilliard Lyons

Acquisition in 2018
Hilliard Lyons, founded in 1854 and based in Louisville, Kentucky, specializes in providing personalized wealth management services and comprehensive advisory solutions. The firm's wealth advisors focus on understanding clients' unique goals and aspirations, creating tailored financial roadmaps to guide them through various stages of their financial lives. Hilliard Lyons also offers merger and acquisition advisory services, business valuation, and exit planning, primarily targeting growth-oriented lower and middle-market companies in the Midwest and Southeast regions. In 2019, Hilliard Lyons' business owner solutions division was acquired by Baird, enhancing its service offerings and market reach.

NeoChord

Series D in 2018
NeoChord, Inc. is a medical technology company based in St. Louis Park, Minnesota, that focuses on developing innovative devices for the treatment of degenerative mitral valve disease (DMR). Founded in 2007, the company has created the NeoChord Artificial Chordae Delivery System, a disposable device designed for minimally invasive mitral valve repair. This system allows surgeons to replace damaged chordae through a small incision of 2 to 3 inches between the ribs, enabling the procedure to be performed on a beating heart. This approach contrasts sharply with traditional methods, which typically involve larger incisions and stopping the heart, thus reducing recovery time and associated complications. NeoChord's technology aims to improve surgical outcomes for patients suffering from severe mitral regurgitation, which can lead to serious conditions such as atrial fibrillation and congestive heart failure.

Zurex Pharma

Series D in 2018
Zurex Pharma, Inc. is a pharmaceutical and medical technology company based in Middleton, Wisconsin, focused on developing and commercializing antimicrobial products aimed at preventing healthcare-associated infections, particularly in surgical site wounds and catheter-related infections. The company’s product lineup includes ZuraPrep, a pre-surgical skin preparation designed to prevent surgical site infections; ZurAsept, an antimicrobial and antithrombotic solution for catheters that helps reduce catheter-related bloodstream infections; and ZuraGard, which protects against exit site wounds. Founded in 2008, Zurex Pharma operates as a subsidiary of Ash Access Technology, Inc., and is dedicated to addressing the challenges of infection control in healthcare settings.

Strata Oncology

Series B in 2018
Strata Oncology, Inc. is a precision oncology company focused on improving cancer care by increasing patient access to clinical trials and expediting drug approvals. The company operates a national precision oncology platform that connects patient screening to streamlined enrollment in mutation-matched clinical trials. Strata collaborates with major healthcare systems to facilitate the genomic sequencing of cancer patients' biopsies in high-throughput laboratories, providing oncologists with timely tumor profiles that inform treatment decisions. Its offerings include The Strata Trial, StrataNGS for targeted DNA and RNA sequencing, and StrataPOINT, which integrates electronic medical records with molecular data to ensure comprehensive testing and follow-up for eligible patients. Strata also manages a portfolio of pharmaceutical-sponsored trials tailored to specific biomarkers and operates the Strata Precision Oncology Network, a collaborative effort among cancer centers to advance precision medicine. Founded in 2015 and headquartered in Ann Arbor, Michigan, Strata was previously known as Strata Oncology Research, Inc. until its name change in May 2016.

Autobooks

Series A in 2018
Autobooks, Inc. is a provider of integrated payment and accounting software tailored for small businesses. Founded in 2015 and based in Detroit, Michigan, the company offers an intelligent, cloud-based platform that seamlessly integrates with bank accounts, facilitating cash flow management, account reconciliation, and business growth. Through its services, Autobooks enables financial institutions to deliver essential back-office functions and an e-commerce platform directly within their digital banking channels. Its product suite includes features for invoicing, bill pay, merchant services, treasury products, and automated accounting, all designed to simplify financial management for small businesses. The company, originally known as Automated Booking, Inc., rebranded to Autobooks, Inc. in March 2018.

Montage

Series D in 2017
Montage is the single solution to engage, interview, and hire better candidates, faster. The company partners with many of the world’s most well-respected brands, including 100 of the Fortune 500, to create the high-tech, high-touch hiring experience the modern candidate expects. As the pioneer of purpose-built video interviewing, its proprietary technology integrates seamlessly with enterprise needs for reliability, scalability, compliance, and security. Montage is committed to market-driven innovation, incorporating applicable science, and data in its solutions to speed the process and improve the predictability of talent acquisition. Its commitment to superior client service and support is unique in the industry. The company helps each and every client at every stage of our partnership because we sincerely want them to succeed – and believe in building relationships for the long term. A privately held company, Montage is headquartered in Wisconsin.

Amphora Medical

Series B in 2017
Amphora Medical, Inc. is a Minnesota-based company that develops medical devices aimed at treating female overactive bladder (OAB) syndrome. Founded in 2011 and headquartered in Maple Grove, Minnesota, the company is focused on creating a novel cystoscopic device designed to enhance bladder function and improve the quality of life for individuals suffering from this condition. Utilizing minimally invasive procedures, Amphora Medical's innovative technology has the potential to offer significant benefits to patients dealing with OAB.

Autobooks

Series A in 2017
Autobooks, Inc. is a provider of integrated payment and accounting software tailored for small businesses. Founded in 2015 and based in Detroit, Michigan, the company offers an intelligent, cloud-based platform that seamlessly integrates with bank accounts, facilitating cash flow management, account reconciliation, and business growth. Through its services, Autobooks enables financial institutions to deliver essential back-office functions and an e-commerce platform directly within their digital banking channels. Its product suite includes features for invoicing, bill pay, merchant services, treasury products, and automated accounting, all designed to simplify financial management for small businesses. The company, originally known as Automated Booking, Inc., rebranded to Autobooks, Inc. in March 2018.

Elucent Medical

Series A in 2017
Elucent Medical LLC is focused on improving breast cancer treatment processes through innovative technology. Founded in 2014 and headquartered in Brookfield, Wisconsin, the company has developed a wireless marker tag and detection system that enhances the surgical excision of breast abnormalities. This advanced surgical navigation technology allows for real-time data processing, enabling surgeons to accurately locate tumor margins and enhance the precision of procedures. By eliminating the need for metal clips, Elucent Medical's solutions aim to simplify breast cancer treatment, making it more accessible and affordable while helping to preserve patients' breasts during surgery. The company's offerings benefit both healthcare providers and patients by improving overall surgical outcomes.

Datica

Series B in 2016
Datica, founded in 2013 and headquartered in Minneapolis, Minnesota, provides a cloud-based healthcare platform designed to facilitate clinical data exchange for highly regulated industries. The platform enables developers to implement cloud-based user management, secure messaging, and data storage without the complexities of server configuration. By supporting common data structures and mandated health services, Datica allows clients, ranging from mid-to-late-stage startups to Fortune 100 companies, to expedite electronic health record (EHR) integration and ensure compliance with cloud regulations. This approach helps organizations manage sensitive information efficiently and securely in the cloud.

Hireology

Series C in 2016
Hireology, Inc. is a Chicago-based company that offers a web-based hiring management software platform designed to help businesses source, engage, and hire top talent. Founded in 2009, it provides an all-in-one solution that streamlines the hiring process by integrating features such as a fully-hosted career site, job postings, pre-hire assessments, and background checks. The platform is particularly tailored for decentralized organizations, including franchise systems, banks, healthcare systems, and dealer networks. By leveraging data on high-performing employees, Hireology's Selection Manager enables organizations to make better hiring decisions, reduce turnover, and enhance productivity across multiple locations. Its comprehensive approach also includes managing employee onboarding, payroll, and benefits, making it a valuable resource for businesses aiming to build effective teams.

Signal

Series E in 2016
Signal Digital, Inc. is a digital marketing technology company that specializes in customer identity solutions for enterprises. Its platform enhances customer experiences by delivering contextual relevance across various engagement points. Key offerings include Onboard to Activate, which effectively targets the right customers while filtering out duplicates, and Onsite Identity Resolution, which identifies anonymous website visitors. Additionally, its Measurement solution provides real-time insights into media impressions and return on investment, enabling marketers to better understand their audiences. Founded in 2009 and headquartered in Chicago, Illinois, Signal also maintains offices in London, Tokyo, and Sydney. As of August 2020, Signal operates as a subsidiary of TransUnion.

Strata Oncology

Series A in 2016
Strata Oncology, Inc. is a precision oncology company focused on improving cancer care by increasing patient access to clinical trials and expediting drug approvals. The company operates a national precision oncology platform that connects patient screening to streamlined enrollment in mutation-matched clinical trials. Strata collaborates with major healthcare systems to facilitate the genomic sequencing of cancer patients' biopsies in high-throughput laboratories, providing oncologists with timely tumor profiles that inform treatment decisions. Its offerings include The Strata Trial, StrataNGS for targeted DNA and RNA sequencing, and StrataPOINT, which integrates electronic medical records with molecular data to ensure comprehensive testing and follow-up for eligible patients. Strata also manages a portfolio of pharmaceutical-sponsored trials tailored to specific biomarkers and operates the Strata Precision Oncology Network, a collaborative effort among cancer centers to advance precision medicine. Founded in 2015 and headquartered in Ann Arbor, Michigan, Strata was previously known as Strata Oncology Research, Inc. until its name change in May 2016.

Synap Software Labs

Seed Round in 2015
Synap Software Labs is a B2B software company based in Chicago, Illinois, founded in 2015. The company specializes in developing a cloud-based relationship management tool called Synap, designed to enhance communication and collaboration among customer-facing teams. Synap simplifies information sharing by integrating team email accounts and other communication tools, automatically compiling a feed of interactions with clients. This platform enables managers and team members to engage in ongoing conversations seamlessly, allows representatives to assist in each other's absence, and facilitates the retrieval of important documents shared via email. By leveraging advancements in the API ecosystem and data analysis, Synap Software Labs focuses on improving customer relationships and creating positive experiences for its users. The company operates as a subsidiary of Imagineer Technology Group, Inc.

NeoChord

Series C in 2015
NeoChord, Inc. is a medical technology company based in St. Louis Park, Minnesota, that focuses on developing innovative devices for the treatment of degenerative mitral valve disease (DMR). Founded in 2007, the company has created the NeoChord Artificial Chordae Delivery System, a disposable device designed for minimally invasive mitral valve repair. This system allows surgeons to replace damaged chordae through a small incision of 2 to 3 inches between the ribs, enabling the procedure to be performed on a beating heart. This approach contrasts sharply with traditional methods, which typically involve larger incisions and stopping the heart, thus reducing recovery time and associated complications. NeoChord's technology aims to improve surgical outcomes for patients suffering from severe mitral regurgitation, which can lead to serious conditions such as atrial fibrillation and congestive heart failure.

eDo Interactive

Series E in 2015
Edo Interactive specializes in a card-linked offer platform designed to bridge the gap between online advertising and in-store results. The company enables advertisers to personalize offers that are automatically accessible through credit cards, debit cards, and mobile devices. By partnering with banks, Edo Interactive delivers targeted offers that leverage trends in digital advertising, personalization, and mobile technology. Headquartered in Nashville, Tennessee, with additional offices in Chicago, New York City, and Atlanta, the company focuses on simplifying the connection between payments and advertising for a seamless consumer experience.

Alpha Source

Acquisition in 2015
Alpha Source, Inc. is a Milwaukee-based company that distributes biomedical repair parts and supplies to the healthcare sector. Founded in 1986, it offers a diverse range of products, including medical replacement lamps, xenon lamps, batteries, patient cables, medical instruments, and various electrical components. The company also manufactures rechargeable battery packs and electrical assemblies utilized in medical equipment and high-tech devices. Additionally, Alpha Source provides repair services for items such as fiber optic cables and blood pressure cuffs, along with recycling services for oxygen sensors. Operating through distributors and direct sales teams, Alpha Source serves customers in the United States and across more than 74 countries. The company is recognized for its innovative solutions in medical equipment maintenance and telemedicine, enhancing patient care and clinical outcomes through a skilled biomedical field services team that offers preventative maintenance, repair services, and training.

Alpha Source

Private Equity Round in 2015
Alpha Source, Inc. is a Milwaukee-based company that distributes biomedical repair parts and supplies to the healthcare sector. Founded in 1986, it offers a diverse range of products, including medical replacement lamps, xenon lamps, batteries, patient cables, medical instruments, and various electrical components. The company also manufactures rechargeable battery packs and electrical assemblies utilized in medical equipment and high-tech devices. Additionally, Alpha Source provides repair services for items such as fiber optic cables and blood pressure cuffs, along with recycling services for oxygen sensors. Operating through distributors and direct sales teams, Alpha Source serves customers in the United States and across more than 74 countries. The company is recognized for its innovative solutions in medical equipment maintenance and telemedicine, enhancing patient care and clinical outcomes through a skilled biomedical field services team that offers preventative maintenance, repair services, and training.

Datica

Series B in 2015
Datica, founded in 2013 and headquartered in Minneapolis, Minnesota, provides a cloud-based healthcare platform designed to facilitate clinical data exchange for highly regulated industries. The platform enables developers to implement cloud-based user management, secure messaging, and data storage without the complexities of server configuration. By supporting common data structures and mandated health services, Datica allows clients, ranging from mid-to-late-stage startups to Fortune 100 companies, to expedite electronic health record (EHR) integration and ensure compliance with cloud regulations. This approach helps organizations manage sensitive information efficiently and securely in the cloud.

NowSecure

Series A in 2014
NowSecure, Inc. specializes in mobile app security testing software and services, providing solutions designed to identify security threats, compliance gaps, and privacy issues in both custom-developed and commercial mobile applications. The company's flagship offerings include the NowSecure Platform, which automates security and privacy testing for mobile apps, and NowSecure Workstation, a comprehensive kit that streamlines mobile app vulnerability assessments. Additionally, NowSecure Data continuously monitors commercial applications for security and compliance risks, while NowSecure Services offers manual penetration testing, developer training, and technical support. Founded in 2009 and headquartered in Chicago, Illinois, NowSecure serves various sectors, including financial services, retail, hospitality, and government. The company emphasizes efficient security testing, aligning its services with Agile and DevSecOps methodologies to ensure that clients can rapidly address vulnerabilities in their mobile applications.

Zurex Pharma

Series B in 2014
Zurex Pharma, Inc. is a pharmaceutical and medical technology company based in Middleton, Wisconsin, focused on developing and commercializing antimicrobial products aimed at preventing healthcare-associated infections, particularly in surgical site wounds and catheter-related infections. The company’s product lineup includes ZuraPrep, a pre-surgical skin preparation designed to prevent surgical site infections; ZurAsept, an antimicrobial and antithrombotic solution for catheters that helps reduce catheter-related bloodstream infections; and ZuraGard, which protects against exit site wounds. Founded in 2008, Zurex Pharma operates as a subsidiary of Ash Access Technology, Inc., and is dedicated to addressing the challenges of infection control in healthcare settings.

Montage

Series C in 2014
Montage is the single solution to engage, interview, and hire better candidates, faster. The company partners with many of the world’s most well-respected brands, including 100 of the Fortune 500, to create the high-tech, high-touch hiring experience the modern candidate expects. As the pioneer of purpose-built video interviewing, its proprietary technology integrates seamlessly with enterprise needs for reliability, scalability, compliance, and security. Montage is committed to market-driven innovation, incorporating applicable science, and data in its solutions to speed the process and improve the predictability of talent acquisition. Its commitment to superior client service and support is unique in the industry. The company helps each and every client at every stage of our partnership because we sincerely want them to succeed – and believe in building relationships for the long term. A privately held company, Montage is headquartered in Wisconsin.

Datica

Venture Round in 2014
Datica, founded in 2013 and headquartered in Minneapolis, Minnesota, provides a cloud-based healthcare platform designed to facilitate clinical data exchange for highly regulated industries. The platform enables developers to implement cloud-based user management, secure messaging, and data storage without the complexities of server configuration. By supporting common data structures and mandated health services, Datica allows clients, ranging from mid-to-late-stage startups to Fortune 100 companies, to expedite electronic health record (EHR) integration and ensure compliance with cloud regulations. This approach helps organizations manage sensitive information efficiently and securely in the cloud.

NeuMoDx Molecular

Series B in 2014
NeuMoDx Molecular, Inc. is a molecular diagnostics company based in Ann Arbor, Michigan, founded in 2012. It specializes in developing solutions for molecular diagnostic testing in hospital and clinical reference laboratories. The company’s platform provides in-vitro testing tools that enhance the efficiency and cost-effectiveness of laboratory operations. By improving the capabilities of laboratory professionals, NeuMoDx aims to increase the adoption of molecular diagnostic testing among medical providers, facilitating earlier and more accurate disease identification and treatment. In 2013, NeuMoDx changed its name from Molecular Systems Corporation and has since become a subsidiary of QIAGEN N.V.

Sittercity

Debt Financing in 2013
Sittercity Incorporated, founded in 2001 and based in Chicago, Illinois, operates an online platform that connects families with local caregivers, including babysitters, nannies, special needs sitters, care companions, and pet sitters. The platform facilitates the screening and hiring process by offering tools such as background checks, motor vehicle records checks, and an online safety guide. Sittercity serves millions of families nationwide, allowing parents to find high-quality care and manage their relationships with caregivers efficiently. The company has also introduced Chime, an on-demand service aimed at simplifying these connections further. As of August 2020, Sittercity operates as a subsidiary of Bright Horizons Family Solutions Inc.

Sittercity

Series C in 2013
Sittercity Incorporated, founded in 2001 and based in Chicago, Illinois, operates an online platform that connects families with local caregivers, including babysitters, nannies, special needs sitters, care companions, and pet sitters. The platform facilitates the screening and hiring process by offering tools such as background checks, motor vehicle records checks, and an online safety guide. Sittercity serves millions of families nationwide, allowing parents to find high-quality care and manage their relationships with caregivers efficiently. The company has also introduced Chime, an on-demand service aimed at simplifying these connections further. As of August 2020, Sittercity operates as a subsidiary of Bright Horizons Family Solutions Inc.

Signal

Series D in 2013
Signal Digital, Inc. is a digital marketing technology company that specializes in customer identity solutions for enterprises. Its platform enhances customer experiences by delivering contextual relevance across various engagement points. Key offerings include Onboard to Activate, which effectively targets the right customers while filtering out duplicates, and Onsite Identity Resolution, which identifies anonymous website visitors. Additionally, its Measurement solution provides real-time insights into media impressions and return on investment, enabling marketers to better understand their audiences. Founded in 2009 and headquartered in Chicago, Illinois, Signal also maintains offices in London, Tokyo, and Sydney. As of August 2020, Signal operates as a subsidiary of TransUnion.

Datica

Series A in 2013
Datica, founded in 2013 and headquartered in Minneapolis, Minnesota, provides a cloud-based healthcare platform designed to facilitate clinical data exchange for highly regulated industries. The platform enables developers to implement cloud-based user management, secure messaging, and data storage without the complexities of server configuration. By supporting common data structures and mandated health services, Datica allows clients, ranging from mid-to-late-stage startups to Fortune 100 companies, to expedite electronic health record (EHR) integration and ensure compliance with cloud regulations. This approach helps organizations manage sensitive information efficiently and securely in the cloud.

eDo Interactive

Venture Round in 2013
Edo Interactive specializes in a card-linked offer platform designed to bridge the gap between online advertising and in-store results. The company enables advertisers to personalize offers that are automatically accessible through credit cards, debit cards, and mobile devices. By partnering with banks, Edo Interactive delivers targeted offers that leverage trends in digital advertising, personalization, and mobile technology. Headquartered in Nashville, Tennessee, with additional offices in Chicago, New York City, and Atlanta, the company focuses on simplifying the connection between payments and advertising for a seamless consumer experience.

Montage

Series B in 2012
Montage is the single solution to engage, interview, and hire better candidates, faster. The company partners with many of the world’s most well-respected brands, including 100 of the Fortune 500, to create the high-tech, high-touch hiring experience the modern candidate expects. As the pioneer of purpose-built video interviewing, its proprietary technology integrates seamlessly with enterprise needs for reliability, scalability, compliance, and security. Montage is committed to market-driven innovation, incorporating applicable science, and data in its solutions to speed the process and improve the predictability of talent acquisition. Its commitment to superior client service and support is unique in the industry. The company helps each and every client at every stage of our partnership because we sincerely want them to succeed – and believe in building relationships for the long term. A privately held company, Montage is headquartered in Wisconsin.

eDo Interactive

Series C in 2012
Edo Interactive specializes in a card-linked offer platform designed to bridge the gap between online advertising and in-store results. The company enables advertisers to personalize offers that are automatically accessible through credit cards, debit cards, and mobile devices. By partnering with banks, Edo Interactive delivers targeted offers that leverage trends in digital advertising, personalization, and mobile technology. Headquartered in Nashville, Tennessee, with additional offices in Chicago, New York City, and Atlanta, the company focuses on simplifying the connection between payments and advertising for a seamless consumer experience.

Zurex Pharma

Series A in 2012
Zurex Pharma, Inc. is a pharmaceutical and medical technology company based in Middleton, Wisconsin, focused on developing and commercializing antimicrobial products aimed at preventing healthcare-associated infections, particularly in surgical site wounds and catheter-related infections. The company’s product lineup includes ZuraPrep, a pre-surgical skin preparation designed to prevent surgical site infections; ZurAsept, an antimicrobial and antithrombotic solution for catheters that helps reduce catheter-related bloodstream infections; and ZuraGard, which protects against exit site wounds. Founded in 2008, Zurex Pharma operates as a subsidiary of Ash Access Technology, Inc., and is dedicated to addressing the challenges of infection control in healthcare settings.

Signal

Series C in 2012
Signal Digital, Inc. is a digital marketing technology company that specializes in customer identity solutions for enterprises. Its platform enhances customer experiences by delivering contextual relevance across various engagement points. Key offerings include Onboard to Activate, which effectively targets the right customers while filtering out duplicates, and Onsite Identity Resolution, which identifies anonymous website visitors. Additionally, its Measurement solution provides real-time insights into media impressions and return on investment, enabling marketers to better understand their audiences. Founded in 2009 and headquartered in Chicago, Illinois, Signal also maintains offices in London, Tokyo, and Sydney. As of August 2020, Signal operates as a subsidiary of TransUnion.

Montage

Venture Round in 2011
Montage is the single solution to engage, interview, and hire better candidates, faster. The company partners with many of the world’s most well-respected brands, including 100 of the Fortune 500, to create the high-tech, high-touch hiring experience the modern candidate expects. As the pioneer of purpose-built video interviewing, its proprietary technology integrates seamlessly with enterprise needs for reliability, scalability, compliance, and security. Montage is committed to market-driven innovation, incorporating applicable science, and data in its solutions to speed the process and improve the predictability of talent acquisition. Its commitment to superior client service and support is unique in the industry. The company helps each and every client at every stage of our partnership because we sincerely want them to succeed – and believe in building relationships for the long term. A privately held company, Montage is headquartered in Wisconsin.

eDo Interactive

Series B in 2011
Edo Interactive specializes in a card-linked offer platform designed to bridge the gap between online advertising and in-store results. The company enables advertisers to personalize offers that are automatically accessible through credit cards, debit cards, and mobile devices. By partnering with banks, Edo Interactive delivers targeted offers that leverage trends in digital advertising, personalization, and mobile technology. Headquartered in Nashville, Tennessee, with additional offices in Chicago, New York City, and Atlanta, the company focuses on simplifying the connection between payments and advertising for a seamless consumer experience.

Sittercity

Series B in 2011
Sittercity Incorporated, founded in 2001 and based in Chicago, Illinois, operates an online platform that connects families with local caregivers, including babysitters, nannies, special needs sitters, care companions, and pet sitters. The platform facilitates the screening and hiring process by offering tools such as background checks, motor vehicle records checks, and an online safety guide. Sittercity serves millions of families nationwide, allowing parents to find high-quality care and manage their relationships with caregivers efficiently. The company has also introduced Chime, an on-demand service aimed at simplifying these connections further. As of August 2020, Sittercity operates as a subsidiary of Bright Horizons Family Solutions Inc.

Celleration

Series E in 2011
Celleration Inc. is a medical device company based in Eden Prairie, Minnesota, founded in 1999. The company specializes in developing and commercializing therapeutic ultrasound technologies for wound care. Its flagship product, the MIST Therapy System, employs low-frequency ultrasound delivered through a saline mist to promote healing by penetrating the wound bed and stimulating cellular activity. Unlike traditional wound treatments, which primarily address the surface, MIST Therapy targets deeper layers to enhance the healing process. Celleration received FDA clearance for this therapy in 2005 and has successfully introduced it to the U.S. market, demonstrating significant clinical and economic benefits across numerous healthcare facilities. To date, over one million MIST Therapy treatments have been administered, positively impacting the lives of more than 65,000 patients. The company operates as a subsidiary of Alliqua BioMedical, Inc.

Montage

Series A in 2010
Montage is the single solution to engage, interview, and hire better candidates, faster. The company partners with many of the world’s most well-respected brands, including 100 of the Fortune 500, to create the high-tech, high-touch hiring experience the modern candidate expects. As the pioneer of purpose-built video interviewing, its proprietary technology integrates seamlessly with enterprise needs for reliability, scalability, compliance, and security. Montage is committed to market-driven innovation, incorporating applicable science, and data in its solutions to speed the process and improve the predictability of talent acquisition. Its commitment to superior client service and support is unique in the industry. The company helps each and every client at every stage of our partnership because we sincerely want them to succeed – and believe in building relationships for the long term. A privately held company, Montage is headquartered in Wisconsin.

CoAxia

Series D in 2009
CoAxia is a medical device company located in Minneapolis, Minnesota, specializing in solutions for cerebral ischemia. The company develops innovative devices aimed at controlling blood flow, specifically the NeuroFlo and FloControl systems. These devices are designed to redirect blood flow to the brain, thereby helping to reduce the risk of stroke and heart attack in patients experiencing conditions such as vasospasm and heart blockage. Through its research and development efforts, CoAxia focuses on improving treatment outcomes for individuals suffering from these serious medical conditions.

Celleration

Series D in 2008
Celleration Inc. is a medical device company based in Eden Prairie, Minnesota, founded in 1999. The company specializes in developing and commercializing therapeutic ultrasound technologies for wound care. Its flagship product, the MIST Therapy System, employs low-frequency ultrasound delivered through a saline mist to promote healing by penetrating the wound bed and stimulating cellular activity. Unlike traditional wound treatments, which primarily address the surface, MIST Therapy targets deeper layers to enhance the healing process. Celleration received FDA clearance for this therapy in 2005 and has successfully introduced it to the U.S. market, demonstrating significant clinical and economic benefits across numerous healthcare facilities. To date, over one million MIST Therapy treatments have been administered, positively impacting the lives of more than 65,000 patients. The company operates as a subsidiary of Alliqua BioMedical, Inc.

CoAxia

Series C in 2008
CoAxia is a medical device company located in Minneapolis, Minnesota, specializing in solutions for cerebral ischemia. The company develops innovative devices aimed at controlling blood flow, specifically the NeuroFlo and FloControl systems. These devices are designed to redirect blood flow to the brain, thereby helping to reduce the risk of stroke and heart attack in patients experiencing conditions such as vasospasm and heart blockage. Through its research and development efforts, CoAxia focuses on improving treatment outcomes for individuals suffering from these serious medical conditions.

CoAxia

Series C in 2006
CoAxia is a medical device company located in Minneapolis, Minnesota, specializing in solutions for cerebral ischemia. The company develops innovative devices aimed at controlling blood flow, specifically the NeuroFlo and FloControl systems. These devices are designed to redirect blood flow to the brain, thereby helping to reduce the risk of stroke and heart attack in patients experiencing conditions such as vasospasm and heart blockage. Through its research and development efforts, CoAxia focuses on improving treatment outcomes for individuals suffering from these serious medical conditions.

Roche NimbleGen

Series F in 2004
Roche NimbleGen specializes in providing a range of products and services for the life science research market, particularly in DNA sequencing and microarray technology. The company offers the SeqCap EZ system, which allows for exome enrichment in a single test tube, along with various design options and reagents to facilitate workflow. Additionally, Roche NimbleGen has developed the SeqCap Epi system for DNA methylation assessment at single-base resolution, and it supplies preparation and adapter kits for library construction. Their proprietary Maskless Array Synthesis technology enables the creation of custom high-density DNA arrays, enhancing the quality and data yield of sequencing efforts. The company also provides a suite of DNA microarray products for applications such as comparative genomic hybridization and gene expression analysis, alongside technical support services. Founded in 1999 and based in Madison, Wisconsin, Roche NimbleGen operates as a subsidiary of Roche Holding AG.

CoAxia

Series B in 2004
CoAxia is a medical device company located in Minneapolis, Minnesota, specializing in solutions for cerebral ischemia. The company develops innovative devices aimed at controlling blood flow, specifically the NeuroFlo and FloControl systems. These devices are designed to redirect blood flow to the brain, thereby helping to reduce the risk of stroke and heart attack in patients experiencing conditions such as vasospasm and heart blockage. Through its research and development efforts, CoAxia focuses on improving treatment outcomes for individuals suffering from these serious medical conditions.

Roche NimbleGen

Series D in 2003
Roche NimbleGen specializes in providing a range of products and services for the life science research market, particularly in DNA sequencing and microarray technology. The company offers the SeqCap EZ system, which allows for exome enrichment in a single test tube, along with various design options and reagents to facilitate workflow. Additionally, Roche NimbleGen has developed the SeqCap Epi system for DNA methylation assessment at single-base resolution, and it supplies preparation and adapter kits for library construction. Their proprietary Maskless Array Synthesis technology enables the creation of custom high-density DNA arrays, enhancing the quality and data yield of sequencing efforts. The company also provides a suite of DNA microarray products for applications such as comparative genomic hybridization and gene expression analysis, alongside technical support services. Founded in 1999 and based in Madison, Wisconsin, Roche NimbleGen operates as a subsidiary of Roche Holding AG.

NetRegulus

Series B in 2003
NetRegulus is a technology company based in Oak Brook, Illinois, that specializes in providing Internet of Things (IoT) and augmented reality (AR) platforms, along with enterprise applications. Founded in 1982, the company focuses on serving manufacturers and businesses by offering solutions that enable the creation, connection, operation, analysis, and servicing of products. Additionally, NetRegulus provides web-based regulatory management software tailored for life science companies, facilitating the effective management of clinical study and quality data. Through its innovative offerings, NetRegulus aims to enhance operational efficiency and regulatory compliance for its clients.

Roche NimbleGen

Series B in 2001
Roche NimbleGen specializes in providing a range of products and services for the life science research market, particularly in DNA sequencing and microarray technology. The company offers the SeqCap EZ system, which allows for exome enrichment in a single test tube, along with various design options and reagents to facilitate workflow. Additionally, Roche NimbleGen has developed the SeqCap Epi system for DNA methylation assessment at single-base resolution, and it supplies preparation and adapter kits for library construction. Their proprietary Maskless Array Synthesis technology enables the creation of custom high-density DNA arrays, enhancing the quality and data yield of sequencing efforts. The company also provides a suite of DNA microarray products for applications such as comparative genomic hybridization and gene expression analysis, alongside technical support services. Founded in 1999 and based in Madison, Wisconsin, Roche NimbleGen operates as a subsidiary of Roche Holding AG.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.